Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Bio-Thera partners with Cipla to market key cancer biosimilar

      Bio-Thera partners with Cipla to market key cancer biosimilar

      Medical Dialogues Bureau15 Jan 2019 9:00 AM IST
      "Bio-Thera is pleased to partner with Cipla to commercialize our lead biosimilar program in select emerging markets," said Dr Shengfeng Li, CEO of...
      Medlife to open 750 retail pharmacies across India by 2020 end

      Medlife to open 750 retail pharmacies across India by 2020 end

      Medical Dialogues Bureau14 Jan 2019 9:45 AM IST
      Medlife is also looking at operating hospital OPD pharmacies and as part of this endeavour going forward, the pharmacies in Fortis Hospitals will be...
      Lupin to focus on developing drugs for CKD and lung cancer

      Lupin to focus on developing drugs for CKD and lung cancer

      Medical Dialogues Bureau14 Jan 2019 9:30 AM IST
      "The Novel Drug Discovery and Development (NDDD) is focused and committed on developing a pipeline of highly differentiated and innovative new...
      Zydus receives final approvals from USFDA for Betamethasone Dipropionate, Amlodipine and Atorvastatin tablets

      Zydus receives final approvals from USFDA for Betamethasone Dipropionate, Amlodipine and Atorvastatin tablets

      Medical Dialogues Bureau14 Jan 2019 9:15 AM IST
      "Betamethasone Dipropionate Cream will be manufactured at the group's Topical manufacturing facility at Ahmedabad," Zydus said in a regulatory...
      Fund battling AIDS, TB and malaria seeks $14 billion to invigorate fight

      Fund battling AIDS, TB and malaria seeks $14 billion to invigorate fight

      Medical Dialogues Bureau12 Jan 2019 9:15 AM IST
      The Global Fund is a group of governments, civil society and private sector partners which invests around $4 billion a year to fight infectious...
      Eli Lilly eyes more cancer deals, but wary of CAR T gene therapy

      Eli Lilly eyes more cancer deals, but wary of CAR T gene therapy

      Medical Dialogues Bureau12 Jan 2019 9:00 AM IST
      Eli Lilly on Monday said it would buy Loxo, which specializes in targeted cancer therapies, in the largest acquisition in the Indianapolis-based...
      Glenmark inks pact with Yuhan Corp to commercialise Ryaltris

      Glenmark inks pact with Yuhan Corp to commercialise Ryaltris

      Medical Dialogues Bureau11 Jan 2019 9:30 AM IST
      In July 2018, Glenmark entered into an exclusive licensing agreement with Seqirus Pty. Ltd. to commercialise Ryaltris in Australia and New Zealand.New...
      Novartis Aimovig not cost effective: UK price watchdog

      Novartis Aimovig not cost effective: UK price watchdog

      Medical Dialogues Bureau11 Jan 2019 9:00 AM IST
      Novartis, whose U.K. price for Aimovig is about 5,000 pounds ($6,374) annually but which was offering discounts, is counting on the medicine to be a...
      J&J faulty hip implants: Review for compensation sought

      J&J faulty hip implants: Review for compensation sought

      Medical Dialogues Bureau10 Jan 2019 10:00 AM IST
      Meanwhile, representatives of the Johnson and Johnson(J&J) also met with the central committee headed by Dr R K Arya during the day.New Delhi:...
      John Mendelsohn, former MD Anderson president, dead

      John Mendelsohn, former MD Anderson president, dead

      Medical Dialogues Bureau10 Jan 2019 9:15 AM IST
      Mendelsohn, who was the president emeritus of prestigious Texas MD Anderson Cancer Centre, was diagnosed of glioblastoma 15 months ago and succumbed...
      Former CEO pleads guilty to fentanyl spray kickback scheme

      Former CEO pleads guilty to fentanyl spray kickback scheme

      Medical Dialogues Bureau10 Jan 2019 9:00 AM IST
      BOSTON - The former chief executive of a company that produces a potentially addictive fentanyl spray pleaded guilty Wednesday to scheming with his...
      Zydus Cadila gets USFDA nod for Aripiprazole tablets

      Zydus Cadila gets USFDA nod for Aripiprazole tablets

      Medical Dialogues Bureau9 Jan 2019 9:45 AM IST
      Aripiprazole, an antipsychotic drug (atypical type), is used to treat mental/mood disorders such as bipolar disorder, schizophrenia, Tourette's...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok